Stimmrechtsanteile: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Mittwoch, 26.07.2017 15:15 von DGAP - Aufrufe: 112

DGAP Voting Rights Announcement: STADA Arzneimittel AG STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 26.07.2017 / 15:12 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany 2. Reason for notification   Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments   Change of breakdown of voting rights   Other reason: 3. Details of person subject to the notification obligation Name: City and country of registered office: Bank of America Corporation Wilmington, DE United States of America (USA) 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached: 20 Jul 2017 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 0.05 % 11.60 % 11.64 % 62342440 Previous notification 1.81 % 8.87 % 10.67 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in %   direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) DE0007251803 0 30448 0.00 % 0.05 % Total 30448 0.05 % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % Prime Brokerage holdings N/A N/A 3156321 5.06 % Right to Recall N/A N/A 3208147 5.15 %     Total 6364468 10.21 % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % Swaps 15.09.2017 N/A Cash 2668 0.00 % Swaps 30.11.2017 N/A Cash 132 0.00 % Swaps 29.03.2018 N/A Cash 235 0.00 % Swaps 30.04.2018 N/A Cash 3300 0.01 % Swaps 27.06.2018 N/A Cash 150000 0.24 % Swaps 03.08.2018 N/A Cash 100000 0.16 % Swaps 10.08.2018 N/A Cash 400000 0.64 % Swaps 14.08.2018 N/A Cash 66400 0.11 % Swaps 28.11.2018 N/A Cash 95000 0.15 % Swaps 25.07.2019 N/A Cash 46632 0.07 %       Total 864367 1.39 % 8. Information in relation to the person subject to the notification obligation   Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) Bank of America Corporation % % % NB Holdings Corporation % % % Merrill Lynch International Incorporated % % % Merrill Lynch Group Holdings I, L.L.C. % % % BofAML Jersey Holdings Limited % % % BofAML EMEA Holdings 1 Limited % % % BofAML EMEA Holdings 2 Limited % % % ML UK Capital Holdings Limited % % % Merrill Lynch International % 10.81 % 10.83 %   Bank of America Corporation % % % NB Holdings Corporation % % % BAC North America Holding Company % % % BANA Holding Corporation % % % Bank of America, National Association % % %   Bank of America Corporation % % % NB Holdings Corporation % % % BAC North America Holding Company % % % Merrill Lynch, Pierce, Fenner & Smith Incorporated % % % Merrill Lynch Professional Clearing Corp. % % %   Bank of America Corporation % % % NB Holdings Corporation % % % BAC North America Holding Company % % % Merrill Lynch, Pierce, Fenner & Smith Incorporated % % %   Bank of America Corporation % % % NB Holdings Corporation % % % Merrill Lynch International Incorporated % % % Merrill Lynch Group Holdings I, L.L.C. % % % Merrill Lynch Equity Scotland Limited Partnership % % % Merrill Lynch Equity S.a.r.l. % % % 9. In case of proxy voting according to Sec. 22 para. 3 WpHG Date of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 26.07.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	STADA Arzneimittel AG
	Stadastraße 2-18
	61118 Bad Vilbel
	Germany
Internet:	www.stada.de

End of News	DGAP News Service

595847  26.07.2017 

E-Mail-Adresse

Bitte überprüfe deine die E-Mail-Adresse.

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

-1

Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.

Andere Nutzer interessierten sich auch für folgende News

25.04.24 - PR Newswire

Moonpig Group Plc - Holding(s) in Company

25.04.24 - PR Newswire

Samson Rock Capital LLP - Form 8.3 - Shanta Gold Ltd

25.04.24 - PR Newswire

Samson Rock Capital LLP - Form 8.3 - Network International Holdings Plc